Close Menu

Immunoassays

News on immunoassay systems and applications.

The submission follows a clinical validation study of the test that analyzed data from samples collected from 400 US and Canadian patients with advanced HR+ breast cancer. 

An initial program aims at the development of a serum neurofilament light chain immunoassay to support Novartis' MS and other neuroscience programs.

The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.

The Swedish firm Biovica said this and additional studies will form the basis of a US Food and Drug Administration submission for its test measuring thymidine kinase-1.

The extended deal covers multiple blood cancer and solid tumor indications and will leverage several HalioDx technologies and approaches.